How effective is erdafitinib?

Erdafitinib is an anti-cancer drug targeting FGFR gene mutations. It is mainly used to treat some metastatic or locally advanced urothelial cancers. It blocks the growth and division of cancer cells by inhibiting the FGFR signaling pathway, thereby inhibiting the development of cancer. In related studies, erdafitinib has shown significant efficacy in some patients with urothelial cancer suffering from FGFR gene mutations. However, individual reactions may vary and may be accompanied by some side effects. Before using erdafitinib or any other anticancer drug, evaluation and treatment planning should be conducted by a physician on a patient-specific basis.